
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals
Daniele Lapa, Daria M. Grousova, Giulia Matusali, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 817-817
Open Access | Times Cited: 29
Daniele Lapa, Daria M. Grousova, Giulia Matusali, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 817-817
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109968-109968
Open Access | Times Cited: 74
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109968-109968
Open Access | Times Cited: 74
Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance
А. С. Шкода, Vladimir А. Gushchin, Darya A. Ogarkova, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 938-938
Open Access | Times Cited: 27
А. С. Шкода, Vladimir А. Gushchin, Darya A. Ogarkova, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 938-938
Open Access | Times Cited: 27
Viral vector and nucleic acid vaccines against COVID-19: A narrative review
Saeed Khoshnood, Roya Ghanavati, Maryam Shirani, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 25
Saeed Khoshnood, Roya Ghanavati, Maryam Shirani, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 25
Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation
Maria G. Byazrova, Sergey V. Kulemzin, Ekaterina A. Astakhova, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Maria G. Byazrova, Sergey V. Kulemzin, Ekaterina A. Astakhova, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study
Sergey Yegorov, Irina Kadyrova, Baurzhan Negmetzhanov, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Sergey Yegorov, Irina Kadyrova, Baurzhan Negmetzhanov, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
COVID-19 Vaccines: An Updated Overview of Different Platforms
D.А. Kudlаy, Andrey Svistunov, Олег Викторович Сатышев
Bioengineering (2022) Vol. 9, Iss. 11, pp. 714-714
Open Access | Times Cited: 19
D.А. Kudlаy, Andrey Svistunov, Олег Викторович Сатышев
Bioengineering (2022) Vol. 9, Iss. 11, pp. 714-714
Open Access | Times Cited: 19
An update on SARS-CoV-2 immunization and future directions
Rashmi Rana, Ravi Kant, Tanya Kumra, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Rashmi Rana, Ravi Kant, Tanya Kumra, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
Ioannis Sitaras, Henning Jacobsen, Melissa M. Higdon, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 16
Ioannis Sitaras, Henning Jacobsen, Melissa M. Higdon, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 16
Dynamics of SARS-CoV-2 Major Genetic Lineages in Moscow in the Context of Vaccine Prophylaxis
Vladimir А. Gushchin, Andrei A. Pochtovyi, Daria D. Kustova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14670-14670
Open Access | Times Cited: 14
Vladimir А. Gushchin, Andrei A. Pochtovyi, Daria D. Kustova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14670-14670
Open Access | Times Cited: 14
Effectiveness of four vaccines in preventing SARS-CoV-2 infection in Almaty, Kazakhstan in 2021: retrospective population-based cohort study
Dilyara Nabirova, Roberta Horth, Manar Smagul, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 8
Dilyara Nabirova, Roberta Horth, Manar Smagul, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 8
Functional Characteristics of Serum Anti-SARS-CoV-2 Antibodies against Delta and Omicron Variants after Vaccination with Sputnik V
Elizaveta I. Radion, Vladimir E. Mukhin, Alyona V. Kholodova, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1349-1349
Open Access | Times Cited: 8
Elizaveta I. Radion, Vladimir E. Mukhin, Alyona V. Kholodova, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1349-1349
Open Access | Times Cited: 8
Sputnik V-induced Antibodies against SARS-CoV-2 Variants during the Dissemination of the Gamma Variant in Venezuela
Christopher Franco, Alejandro Cornejo, Mariajosé Rodríguez, et al.
(2024)
Open Access | Times Cited: 2
Christopher Franco, Alejandro Cornejo, Mariajosé Rodríguez, et al.
(2024)
Open Access | Times Cited: 2
Characterisation of the COVID-19 epidemic process in Moscow and search for possible determinants of the trends of the observed changes
Vladimir А. Gushchin, Andrei A. Pochtovyi, Daria D. Kustova, et al.
Journal of microbiology epidemiology immunobiology (2023) Vol. 100, Iss. 4, pp. 267-284
Open Access | Times Cited: 5
Vladimir А. Gushchin, Andrei A. Pochtovyi, Daria D. Kustova, et al.
Journal of microbiology epidemiology immunobiology (2023) Vol. 100, Iss. 4, pp. 267-284
Open Access | Times Cited: 5
Microarray Profiling of Vaccination-Induced Antibody Responses to SARS-CoV-2 Variants of Interest and Concern
Julia Svetlova, Dmitry Gustin, Valentin A. Manuvera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13220-13220
Open Access | Times Cited: 8
Julia Svetlova, Dmitry Gustin, Valentin A. Manuvera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13220-13220
Open Access | Times Cited: 8
Evaluation of febrile seizures in children infected with SARS-CoV-2 Omicron variant in Yunnan, China: a multi-center, retrospective observational study
Haifeng Liu, Rui Lü, Jian Yang, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 4
Haifeng Liu, Rui Lü, Jian Yang, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 4
To be remembered: B cell memory response against SARS‐CoV ‐2 and its variants in vaccinated and unvaccinated individuals
Nafees Ahmed, Atharv Athavale, Ankita Tripathi, et al.
Scandinavian Journal of Immunology (2023) Vol. 99, Iss. 2
Open Access | Times Cited: 4
Nafees Ahmed, Atharv Athavale, Ankita Tripathi, et al.
Scandinavian Journal of Immunology (2023) Vol. 99, Iss. 2
Open Access | Times Cited: 4
Geopolitical aspects of COVID-19 vaccines distribution
Giulio de Felice, Nihal Tutal, Nicolina Sciaraffa
European Journal of Environment and Public Health (2023) Vol. 7, Iss. 3, pp. em0132-em0132
Open Access | Times Cited: 3
Giulio de Felice, Nihal Tutal, Nicolina Sciaraffa
European Journal of Environment and Public Health (2023) Vol. 7, Iss. 3, pp. em0132-em0132
Open Access | Times Cited: 3
Methodology for evaluation of the level of IgG antibodies against different SARS-CoV-2 proteins using multiplex immunofluorescence analysis
L.V. Frolova, P.Yu. Zemsky, Sergey I. Mitrofanov, et al.
Immunologiya (2023) Vol. 44, Iss. 1, pp. 109-119
Open Access | Times Cited: 3
L.V. Frolova, P.Yu. Zemsky, Sergey I. Mitrofanov, et al.
Immunologiya (2023) Vol. 44, Iss. 1, pp. 109-119
Open Access | Times Cited: 3
Dynamic assessment of the intensity of the immune response to SARS-CoV-2 infection and immunization against COVID-19 with the vaccine «Sputnik V»
K.O. Nechay, A.I. Andreev, Igor Andreev, et al.
Immunologiya (2023) Vol. 44, Iss. 2, pp. 157-166
Open Access | Times Cited: 2
K.O. Nechay, A.I. Andreev, Igor Andreev, et al.
Immunologiya (2023) Vol. 44, Iss. 2, pp. 157-166
Open Access | Times Cited: 2
Inactivated whole virion vaccine protects K18‐hACE2 Tg mice against the Omicron SARS‐CoV‐2 variant via cross‐reactive T cells and nonneutralizing antibody responses
Andrey Kruglov, Marina Bondareva, Violetta S. Gogoleva, et al.
European Journal of Immunology (2023) Vol. 54, Iss. 3
Open Access | Times Cited: 2
Andrey Kruglov, Marina Bondareva, Violetta S. Gogoleva, et al.
European Journal of Immunology (2023) Vol. 54, Iss. 3
Open Access | Times Cited: 2
European Journal of Environment and Public Health
European Journal of Environment and Public Health (2019)
Open Access | Times Cited: 6
European Journal of Environment and Public Health (2019)
Open Access | Times Cited: 6
Epidemiological Features of the COVID-19 and Characteristics of Patients during the Spread of the Omicron SARS-COV-2 in Russia
A. A. Fomicheva, Nikolay Pimenov, S. V. Komarova, et al.
Epidemiology and Vaccinal Prevention (2024) Vol. 23, Iss. 4, pp. 116-127
Open Access
A. A. Fomicheva, Nikolay Pimenov, S. V. Komarova, et al.
Epidemiology and Vaccinal Prevention (2024) Vol. 23, Iss. 4, pp. 116-127
Open Access
Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5
Inna V. Dolzhikova, А. И. Тухватулин, Daria M. Grousova, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1152-1152
Open Access
Inna V. Dolzhikova, А. И. Тухватулин, Daria M. Grousova, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1152-1152
Open Access
Effectiveness of Sputnik V, Qazvac, Hayat-Vax, and Coronavac Vaccines in Preventing COVID-19 in Kazakhstan, February-September 2021
Dilyara Nabirova, Roberta Horth, Manar Smagul, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 2
Dilyara Nabirova, Roberta Horth, Manar Smagul, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 2